Galmed Pharmaceuticals

152 articles about Galmed Pharmaceuticals

• Galmed Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update

  11/9/2017

  A conference call and webcast is scheduled for oday at 8:30 a.m. ET / 5:30 a.m. PT.

• Galmed Pharmaceuticals to Report Third Quarter Financial Results on Thursday, November 9th

  11/1/2017

  Galmed Pharma today announced that it will host a conference call and webcast to discuss results for the three and nine months ended September 30, 2017 and to provide an update on current developments with respect to its clinical programs for Aramchol on Thursday, November 9, 2017.

• Galmed Pharmaceuticals Announces Publication Of Data On Aramchol Mechanism Of Action In Hepatology Communications. Data Will Also Be Presented At AASLD

  10/5/2017

• Galmed Pharmaceuticals Announces Pricing Of Offering Of Ordinary Shares To Existing Investors And Members Of The Board Of Directors

  8/4/2017

• Galmed Pharmaceuticals Reports Second Quarter 2017 Financial Results And Provides Business Update

  7/31/2017

• Galmed Pharmaceuticals Second Quarter 2017 Conference Call And Webcast Scheduled For Monday, July 31, 2017

  7/24/2017

• Galmed Pharmaceuticals Announces The Election Of Dr. Carol L. Brosgart As A New Member Of The Board Of Directors

  6/8/2017

• Galmed Pharmaceuticals Reports First Quarter 2017 Financial Results

  5/15/2017

• Galmed Pharmaceuticals First Quarter 2017 Conference Call And Webcast Scheduled For Monday, May 15th, 2017

  5/8/2017

• Galmed Pharmaceuticals Reports Fourth Quarter And Full Year 2016 Financial Results

  3/23/2017

• Galmed Pharmaceuticals Fourth Quarter 2016 Conference Call And Webcast Scheduled For Thursday, March 23rd, 2017

  3/16/2017

• Galmed Pharmaceuticals Completes Patient Recruitment For ARREST Phase IIb NASH Study

  1/9/2017

• Galmed Pharmaceuticals Reports Third Quarter 2016 Financial Results And Provides Business Update

  11/8/2016

• Galmed Pharmaceuticals Third Quarter 2016 Conference Call And Webcast Scheduled For Monday, November 7th, 2016

  10/31/2016

• Galmed Pharmaceuticals Announces That It Has Raised Approximately $5.0 Million To Date Under Its ATM Program

  9/29/2016

• Galmed Pharmaceuticals And The University of California, San Diego (UCSD) Enter Into An Investigator-Initiated Clinical Trial Agreement To Assess Aramchol Effects Juvenile Population

  9/23/2016

• Galmed Pharmaceuticals Announces The Appointment Of Dr. Liat Hayardeny, Ph.D. MBA, As Chief Scientific Officer

  9/8/2016

• Galmed Pharmaceuticals Reports Second Quarter 2016 Financial Results And Provides Business Update

  8/3/2016

• Galmed Pharmaceuticals Announces The Appointment Of Professor Ran Oren, M.D., As Chief Medical Officer

  8/1/2016

• Galmed Pharmaceuticals And Samil Pharm Sign A License Agreement For The Commercialization Of Aramchol In Korea

  7/28/2016